StressMarq Biosciences manufactures high quality, cutting edge research products for the life sciences and drug discovery/biopharma markets.
StressMarq is the market leader in the development and commercialization of a broad range of fibrilized, oligomeric and monomeric protein constructs for use in neurodegenerative disease research, including alpha synuclein, tau, amyloid beta, SOD1 and TTR. StressMarq’s strategic efforts are focused on expanding the breadth and depth of this product offering to assist researchers studying Alzheimer’s, Parkinson’s, and other neurodegenerative diseases.
In addition to neurodegenerative disease research products, StressMarq's diverse portfolio of antibodies, proteins, kits and small molecules are utilized in neuroscience, cancer research and cell signaling. StressMarq products are available directly in the USA & Canada, and through an extensive network of international distributors in over 45 countries.